Taro Pharmaceutical Industries (Taro Pharmaceutical Industries) Price-to-Tangible-Book : 0.91 (As of May. 03, 2024)

View and export this data going back to 1987. Start your Free Trial

What is Taro Pharmaceutical Industries Price-to-Tangible-Book?

As of today (2024-05-03), Taro Pharmaceutical Industries's share price is $42.45. Taro Pharmaceutical Industries's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was $46.88. Hence, Taro Pharmaceutical Industries's Price to Tangible Book Ratio of today is 0.91.

The historical rank and industry rank for Taro Pharmaceutical Industries's Price-to-Tangible-Book or its related term are showing as below:

TARO' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.56 Med: 1.79 Max: 5.56
Current: 0.91

During the past 13 years, Taro Pharmaceutical Industries's highest Price to Tangible Book Ratio was 5.56. The lowest was 0.56. And the median was 1.79.

TARO's Price-to-Tangible-Book is ranked better than
86.48% of 873 companies
in the Drug Manufacturers industry
Industry Median: 2.34 vs TARO: 0.91

A closely related ratio is called PB Ratio. As of today, Taro Pharmaceutical Industries's share price is $42.45. Taro Pharmaceutical Industries's Book Value per Sharefor the quarter that ended in Dec. 2023 was $47.34. Hence, Taro Pharmaceutical Industries's P/B Ratio of today is 0.90.

Taro Pharmaceutical Industries Price-to-Tangible-Book Historical Data

The historical data trend for Taro Pharmaceutical Industries's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Taro Pharmaceutical Industries Price-to-Tangible-Book Chart

Taro Pharmaceutical Industries Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Price-to-Tangible-Book

Get a 7-Day Free Trial

2.22

1.13

1.67

0.99

0.56

Taro Pharmaceutical Industries Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial															-	0.56	0.83	0.82	0.89

Competitive Comparison of Taro Pharmaceutical Industries's Price-to-Tangible-Book

For the Drug Manufacturers - Specialty & Generic subindustry, Taro Pharmaceutical Industries's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Taro Pharmaceutical Industries's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Taro Pharmaceutical Industries's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Taro Pharmaceutical Industries's Price-to-Tangible-Book falls into.

Taro Pharmaceutical Industries Price-to-Tangible-Book Calculation

Taro Pharmaceutical Industries's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	42.45	/	46.877
	=	0.91

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Taro Pharmaceutical Industries Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Taro Pharmaceutical Industries's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Taro Pharmaceutical Industries (Taro Pharmaceutical Industries) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Taro Pharmaceutical Industries Ltd (NYSE:TARO) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

TAL:Germany

Address

14 Hakitor Street, P.O. Box 10347, Haifa Bay, Haifa, ISR, 2624761

Website

https://www.taro.com

Taro Pharmaceutical Industries Ltd produces, researches, develops, and markets pharmaceutical products. Its primary focus includes semi-solid formulations, such as creams and ointments, and other dosage forms such as liquids, capsules, and tablets. The company is engaged in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Israel, and Other Countries.

Executives

Sun Pharma Global Inc	10 percent owner
Sun Pharmaceutical Industries Ltd	10 percent owner, other: Affiliated Party	17/B, MAHAL INDUSTRIAL ESTATE, MAHAKALI CAVES ROAD, ANDEHERI (EAST) K7 400 093
Alkaloida Chemical Co Exclusive Group Ltd.	10 percent owner	KABAY JANOS UT 29., TISZAVASVARI K5 4440
Franklin Resources Inc	10 percent owner	FRANKLIN RESOURCES INC, ONE FRANKLIN PARKWAY, SAN MATEO CA 94403